CIK: 0001595851
Total reported value
$331.0M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | RETAEUR | Reata Pharmaceuticals Inc-a | Stock-Other | 9.94% | — | -26.00% | |
| 2 | SRPT | Sarepta Therapeutics INC | Stock-Healthcare | 7.54% | — | +236.36% | |
| 3 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 6.76% | — | — | |
| 4 | TGTX | Tg Therapeutics INC | Stock-Healthcare | 4.89% | — | — | |
| 5 | APLSUSD | Apellis Pharmaceuticals INC | Stock-Other | 4.22% | — | -27.83% | |
| 6 | AMLX | Amylyx Pharmaceuticals INC | Stock-Other | 4.12% | — | +35.71% | |
| 7 | AXSM | Axsome Therapeutics INC | Stock-Healthcare | 4.10% | — | -4.26% | |
| 8 | ASND | Ascendis Pharma A/S | Stock-Other | 3.49% | — | -15.38% | |
| 9 | AKRO | Akero Therapeutics INC | Stock-Other | 3.11% | — | +223.53% | |
| 10 | VKTX | Viking Therapeutics INC | Stock-Healthcare | 2.95% | — | +100.00% | |
| 11 | PCVX | Vaxcyte INC | Stock-Other | 2.49% | — | +40.63% | |
| 12 | CTIC1USD | Cti Biopharma CORP | Stock-Other | 2.48% | — | +8.11% | |
| 13 | PFE | Pfizer INC | Stock-Healthcare | 2.41% | — | — | |
| 14 | RVNCEUR | Revance Therapeutics INC | Stock-Other | 2.38% | — | -16.67% | |
| 15 | JNJ | Johnson & Johnson | Stock-Healthcare | 2.29% | — | — | |
| 16 | QURE | uniQure N.V. | Stock-Other | 2.23% | — | — | |
| 17 | MDGL | Madrigal Pharmaceuticals INC | Stock-Healthcare | 2.15% | — | +50.00% | |
| 18 | XENE | Xenon Pharmaceuticals INC | Stock-Other | 2.12% | — | — | |
| 19 | SNDX | Syndax Pharmaceuticals INC | Stock-Other | 2.03% | — | +116.67% | |
| 20 | IOVA | Iovance Biotherapeutics INC | Stock-Other | 1.81% | — | -23.08% | |
| 21 | CATBUSD | Astria Therapeutics INC | Stock-Other | 1.77% | — | — | |
| 22 | COGT | Cogent Biosciences INC | Stock-Other | 1.75% | — | -31.25% | |
| 23 | INCY | Incyte CORP | Stock-Healthcare | 1.60% | — | — | |
| 24 | AM6 | Amicus Therapeutics INC | Stock-Other | 1.56% | — | — | |
| 25 | MRTXEUR | Mirati Therapeutics INC | Stock-Other | 1.54% | — | -30.00% | |
| 26 | PTGX | Protagonist Therapeutics INC | Stock-Other | 1.53% | — | — | |
| 27 | ETNBGBP | 89bio INC | Stock-Other | 1.35% | — | — | |
| 28 | VRDN | Viridian Therapeutics INC | Stock-Other | 1.32% | — | +6.06% | |
| 29 | OPHTEUR | Iveric Bio INC | Stock-Other | 1.26% | — | -61.11% | |
| 30 | MLTX | Moonlake Immunotherapeutics | Stock-Other | 1.23% | — | — | |
| 31 | ✓ | Stock-Other | 1.19% | — | +48.15% | ||
| 32 | BMEA | Biomea Fusion INC | Stock-Other | 1.10% | — | — | |
| 33 | ACRS | Aclaris Therapeutics INC | Stock-Other | 1.02% | — | — | |
| 34 | ✓ | Stock-Other | 0.94% | — | -56.25% | ||
| 35 | BCRX | Biocryst Pharmaceuticals INC | Stock-Other | 0.68% | — | +22.22% | |
| 36 | ✓ | Stock-Other | 0.66% | — | — | ||
| 37 | ✓ | Rain Oncology INC Com | Stock-Other | 0.65% | — | — | |
| 38 | IRON | Disc Medicine INC | Stock-Other | 0.63% | — | — | |
| 39 | RNAGBP | Avidity Biosciences INC | Stock-Other | 0.57% | — | +25.00% | |
| 40 | ALT | Altimmune INC | Stock-Other | 0.50% | — | — | |
| 41 | ✓ | Stock-Other | 0.48% | — | +51.58% | ||
| 42 | NVLSEUR | Alpine Immune Sciences INC | Stock-Other | 0.46% | — | — | |
| 43 | RCUS | Arcus Biosciences INC | Stock-Other | 0.40% | — | — | |
| 44 | ✓ | Fusion Pharmaceuticals INC | Stock-Other | 0.39% | — | — | |
| 45 | WHWK | Whitehawk Therapeutics INC | Stock-Other | 0.32% | — | +66.67% | |
| 46 | TARS | Tarsus Pharmaceuticals INC | Stock-Other | 0.30% | — | — | |
| 47 | GERN | Geron CORP | Stock-Other | 0.29% | — | — | |
| 48 | ASNSUSD | X4 Pharmaceuticals INC | Stock-Other | 0.22% | — | -15.00% | |
| 49 | SWTXUSD | Springworks Therapeutics INC | Stock-Other | 0.21% | — | — | |
| 50 | ✓ | Stock-Other | 0.16% | — | -48.52% |